nodes	percent_of_prediction	percent_of_DWPC	metapath
Carbinoxamine—CYP2C8—Spironolactone—dilated cardiomyopathy	0.265	1	CbGbCtD
Carbinoxamine—Drug eruption—Spironolactone—dilated cardiomyopathy	0.0569	0.0803	CcSEcCtD
Carbinoxamine—Drug eruption—Furosemide—dilated cardiomyopathy	0.031	0.0437	CcSEcCtD
Carbinoxamine—Drowsiness—Spironolactone—dilated cardiomyopathy	0.0196	0.0276	CcSEcCtD
Carbinoxamine—Agranulocytosis—Spironolactone—dilated cardiomyopathy	0.0183	0.0258	CcSEcCtD
Carbinoxamine—Chest discomfort—Lisinopril—dilated cardiomyopathy	0.0161	0.0228	CcSEcCtD
Carbinoxamine—Photosensitivity—Furosemide—dilated cardiomyopathy	0.0157	0.0222	CcSEcCtD
Carbinoxamine—Haemolytic anaemia—Furosemide—dilated cardiomyopathy	0.0153	0.0216	CcSEcCtD
Carbinoxamine—Wheezing—Lisinopril—dilated cardiomyopathy	0.0139	0.0196	CcSEcCtD
Carbinoxamine—Mepyramine—SLC22A5—dilated cardiomyopathy	0.0136	0.509	CrCbGaD
Carbinoxamine—Irritability—Furosemide—dilated cardiomyopathy	0.0132	0.0186	CcSEcCtD
Carbinoxamine—Urinary retention—Furosemide—dilated cardiomyopathy	0.0131	0.0186	CcSEcCtD
Carbinoxamine—Confusional state—Spironolactone—dilated cardiomyopathy	0.0126	0.0178	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.0122	0.0173	CcSEcCtD
Carbinoxamine—Photosensitivity—Lisinopril—dilated cardiomyopathy	0.0118	0.0167	CcSEcCtD
Carbinoxamine—Haemolytic anaemia—Lisinopril—dilated cardiomyopathy	0.0115	0.0162	CcSEcCtD
Carbinoxamine—Nasal congestion—Lisinopril—dilated cardiomyopathy	0.0114	0.0161	CcSEcCtD
Carbinoxamine—Somnolence—Spironolactone—dilated cardiomyopathy	0.0111	0.0157	CcSEcCtD
Carbinoxamine—Pollakiuria—Furosemide—dilated cardiomyopathy	0.011	0.0156	CcSEcCtD
Carbinoxamine—Photosensitivity reaction—Furosemide—dilated cardiomyopathy	0.0109	0.0154	CcSEcCtD
Carbinoxamine—Drowsiness—Furosemide—dilated cardiomyopathy	0.0107	0.015	CcSEcCtD
Carbinoxamine—Diplopia—Lisinopril—dilated cardiomyopathy	0.0104	0.0146	CcSEcCtD
Carbinoxamine—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.0103	0.0145	CcSEcCtD
Carbinoxamine—Agranulocytosis—Furosemide—dilated cardiomyopathy	0.00994	0.014	CcSEcCtD
Carbinoxamine—Urticaria—Spironolactone—dilated cardiomyopathy	0.00992	0.014	CcSEcCtD
Carbinoxamine—Irritability—Lisinopril—dilated cardiomyopathy	0.0099	0.014	CcSEcCtD
Carbinoxamine—Tinnitus—Furosemide—dilated cardiomyopathy	0.00891	0.0126	CcSEcCtD
Carbinoxamine—Sweating increased—Lisinopril—dilated cardiomyopathy	0.00873	0.0123	CcSEcCtD
Carbinoxamine—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00854	0.0121	CcSEcCtD
Carbinoxamine—Dizziness—Spironolactone—dilated cardiomyopathy	0.00826	0.0117	CcSEcCtD
Carbinoxamine—Photosensitivity reaction—Lisinopril—dilated cardiomyopathy	0.00818	0.0115	CcSEcCtD
Carbinoxamine—Orphenadrine—SCN5A—dilated cardiomyopathy	0.00816	0.305	CrCbGaD
Carbinoxamine—Vomiting—Spironolactone—dilated cardiomyopathy	0.00794	0.0112	CcSEcCtD
Carbinoxamine—Vision blurred—Furosemide—dilated cardiomyopathy	0.00784	0.0111	CcSEcCtD
Carbinoxamine—Neuropathy peripheral—Lisinopril—dilated cardiomyopathy	0.00783	0.0111	CcSEcCtD
Carbinoxamine—Headache—Spironolactone—dilated cardiomyopathy	0.00782	0.011	CcSEcCtD
Carbinoxamine—Agitation—Furosemide—dilated cardiomyopathy	0.00765	0.0108	CcSEcCtD
Carbinoxamine—Vertigo—Furosemide—dilated cardiomyopathy	0.00748	0.0106	CcSEcCtD
Carbinoxamine—Agranulocytosis—Lisinopril—dilated cardiomyopathy	0.00746	0.0105	CcSEcCtD
Carbinoxamine—Nausea—Spironolactone—dilated cardiomyopathy	0.00742	0.0105	CcSEcCtD
Carbinoxamine—Confusional state—Furosemide—dilated cardiomyopathy	0.00685	0.00967	CcSEcCtD
Carbinoxamine—Tinnitus—Lisinopril—dilated cardiomyopathy	0.00669	0.00944	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.00665	0.00939	CcSEcCtD
Carbinoxamine—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.00657	0.00927	CcSEcCtD
Carbinoxamine—Anorexia—Furosemide—dilated cardiomyopathy	0.00648	0.00914	CcSEcCtD
Carbinoxamine—Chills—Lisinopril—dilated cardiomyopathy	0.00644	0.00909	CcSEcCtD
Carbinoxamine—Hypotension—Furosemide—dilated cardiomyopathy	0.00635	0.00896	CcSEcCtD
Carbinoxamine—Tension—Lisinopril—dilated cardiomyopathy	0.00613	0.00865	CcSEcCtD
Carbinoxamine—Paraesthesia—Furosemide—dilated cardiomyopathy	0.0061	0.00861	CcSEcCtD
Carbinoxamine—Nervousness—Lisinopril—dilated cardiomyopathy	0.00607	0.00856	CcSEcCtD
Carbinoxamine—Somnolence—Furosemide—dilated cardiomyopathy	0.00604	0.00852	CcSEcCtD
Carbinoxamine—Decreased appetite—Furosemide—dilated cardiomyopathy	0.0059	0.00834	CcSEcCtD
Carbinoxamine—Vision blurred—Lisinopril—dilated cardiomyopathy	0.00589	0.00831	CcSEcCtD
Carbinoxamine—Fatigue—Furosemide—dilated cardiomyopathy	0.00586	0.00827	CcSEcCtD
Carbinoxamine—Tremor—Lisinopril—dilated cardiomyopathy	0.00585	0.00826	CcSEcCtD
Carbinoxamine—Constipation—Furosemide—dilated cardiomyopathy	0.00581	0.0082	CcSEcCtD
Carbinoxamine—Vertigo—Lisinopril—dilated cardiomyopathy	0.00561	0.00792	CcSEcCtD
Carbinoxamine—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.0056	0.0079	CcSEcCtD
Carbinoxamine—Palpitations—Lisinopril—dilated cardiomyopathy	0.00552	0.00779	CcSEcCtD
Carbinoxamine—Urticaria—Furosemide—dilated cardiomyopathy	0.0054	0.00762	CcSEcCtD
Carbinoxamine—Confusional state—Lisinopril—dilated cardiomyopathy	0.00514	0.00725	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.00499	0.00704	CcSEcCtD
Carbinoxamine—Tachycardia—Lisinopril—dilated cardiomyopathy	0.00497	0.00702	CcSEcCtD
Carbinoxamine—Diphenhydramine—SLC22A5—dilated cardiomyopathy	0.00497	0.186	CrCbGaD
Carbinoxamine—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.00493	0.00696	CcSEcCtD
Carbinoxamine—Asthenia—Furosemide—dilated cardiomyopathy	0.00487	0.00688	CcSEcCtD
Carbinoxamine—Anorexia—Lisinopril—dilated cardiomyopathy	0.00486	0.00686	CcSEcCtD
Carbinoxamine—Hypotension—Lisinopril—dilated cardiomyopathy	0.00476	0.00672	CcSEcCtD
Carbinoxamine—Diarrhoea—Furosemide—dilated cardiomyopathy	0.00465	0.00656	CcSEcCtD
Carbinoxamine—Insomnia—Lisinopril—dilated cardiomyopathy	0.00461	0.00651	CcSEcCtD
Carbinoxamine—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.00458	0.00646	CcSEcCtD
Carbinoxamine—Somnolence—Lisinopril—dilated cardiomyopathy	0.00453	0.0064	CcSEcCtD
Carbinoxamine—Dizziness—Furosemide—dilated cardiomyopathy	0.00449	0.00634	CcSEcCtD
Carbinoxamine—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.00449	0.00633	CcSEcCtD
Carbinoxamine—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.00443	0.00625	CcSEcCtD
Carbinoxamine—Fatigue—Lisinopril—dilated cardiomyopathy	0.00439	0.0062	CcSEcCtD
Carbinoxamine—Constipation—Lisinopril—dilated cardiomyopathy	0.00436	0.00615	CcSEcCtD
Carbinoxamine—Vomiting—Furosemide—dilated cardiomyopathy	0.00432	0.0061	CcSEcCtD
Carbinoxamine—Headache—Furosemide—dilated cardiomyopathy	0.00426	0.00601	CcSEcCtD
Carbinoxamine—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.0042	0.00593	CcSEcCtD
Carbinoxamine—Urticaria—Lisinopril—dilated cardiomyopathy	0.00405	0.00572	CcSEcCtD
Carbinoxamine—Nausea—Furosemide—dilated cardiomyopathy	0.00403	0.0057	CcSEcCtD
Carbinoxamine—Asthenia—Lisinopril—dilated cardiomyopathy	0.00366	0.00516	CcSEcCtD
Carbinoxamine—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.00349	0.00492	CcSEcCtD
Carbinoxamine—Dizziness—Lisinopril—dilated cardiomyopathy	0.00337	0.00476	CcSEcCtD
Carbinoxamine—Vomiting—Lisinopril—dilated cardiomyopathy	0.00324	0.00457	CcSEcCtD
Carbinoxamine—Headache—Lisinopril—dilated cardiomyopathy	0.00319	0.00451	CcSEcCtD
Carbinoxamine—Nausea—Lisinopril—dilated cardiomyopathy	0.00303	0.00427	CcSEcCtD
